Focus on Start-up Pitch Day: BVMed, Earlybird, High-Tech Gründerfonds and BIOCOM publish “MedTech Radar 10”
March 28, 2018
Strategic co-operation between medical technology firms and start-ups could foster more innovation within the industry and be a decisive factor in the success of small and medium-sized businesses (SMEs). This is particularly true in light of the increasingly complex regulatory market environment through the new EU Medical Device Regulation (MDR) which came into effect almost a year ago. Which advantages start-ups could bring in with regard to this situation and what founders, investors as well as established medical technology companies can expect from the Start-up Pitches at “MedTech Radar Live 2018” is highlighted in the 10th edition of the joint media service “MedTech Radar”, published by the German Medical Technology Association (BVMed), Earlybird Venture Capital, High-Tech Gründerfonds (HTGF) and BIOCOM AG.
The current MedTech Radar is available for download in German or English
Since the EU MDR entered into force in May 2017, small to medium-sized medical technology companies in particular have to spend most of their resources on handling and rearranging the regulatory requirements. But how can the innovation capacities of the sector be preserved despite this environment? Which potential do strategic co-operations with start-ups offer? Which aspects of the medical technology market should be considered by founders with respect to the development of new products and services?
The current edition of “MedTech Radar” provides a preview of the Start-up Pitch Day “MedTech Radar Live 2018” on 16th May 2018 in Cologne. The call for applications is open until 31st March. Particularly wanted are smart ideas with a focus on Digital Health, Services, Rehabilitation, Patient Care & Big Data. The event offers 10 start-ups the opportunity to present their business ideas to the public, receive direct feedback from an expert jury and establish valuable contacts with the medical technology industry, with statutory health insurance experts as well as investors and other sector stakeholders. In addition, the 10 business models will be published in the 11th issue of the “MedTech Radar”.
Among the jury members of the Start-up Pitch Day is Marc Michel, CEO of endoprosthesis specialist and BVMed member company Peter Brehm GmbH. He highlights: “The industry is currently facing a multitude of challenges. Individual companies, in particular small to medium-sized enterprises, do not have the resources to manage these alone.” In an interview in the “MedTech Radar” he talks about his experiences with start-ups and why the industry should co-operate with founders in the future.
“MedTech Radar Live 2018” is backed by the German Medical Technology Association (BVMed), the investors Earlybird Venture Capital and High-Tech Gründerfonds (HTGF), BARMER and the medical technology journal medtech zwo. The event’s patron is the Minister for Economics, Innovation, Digitisation and Energy in North Rhine-Westphalia, Dr. Andreas Pinkwart. Another local partner on board is the investor NRW.Bank.
Summarized facts:
> Interested founders can apply until 31st March 2018.
> Details about the Start-up Pitch Day and the jury are available here: www.medtechradar.live
> The registration for the „MedTech Radar Live 2018“ event on 16th May 2018 in Cologne is possible here: www.bvmed.de/events.
About the publishers:
The High-Tech Gründerfonds invests risk capital in young technology companies that implement promising research results into business strategies.
Earlybird Venture Capital is one of the most successful European venture capital investors and currently manages over 850 million Euros of capital for an international investor base. In August 2016, it launched a new health-tech fund in which the insurance companies BARMER and Generali as well as the family-owned company Miele participated. Earlybird invests in innovative technology companies in Europe and, among others, has equities in Miracor Medical Systems and Atlantic Therapeutics.
The German Medical Technology Association (BVMed) is an industry association that represents over 230 industrial and commercial companies in the medical technology sector.
As an information specialist, BIOCOM AG has supported the life sciences with journals, websites and books for more than 30 years. The “medtech zwo” magazine and the news portal report on start-ups, deals and financings relating to the medtech sectors in Germany, Austria and Switzerland.
V.i.S.d.P:
BVMed – Bundesverband Medizintechnologie, Reinhardtstr. 29 b, 10117 Berlin
Manfred Beeres, Leiter Kommunikation/Presse; Tel. +49 – 30 246 255-20, beeres@bvmed.de, www.bvmed.de
Earlybird Venture Capital, Münzstr. 21, 10178 Berlin
Catrin Schmidt; Tel. +49 – 30 46724700, catrin@earlybird.com, www.earlybird.com
High-Tech Gründerfonds Management GmbH, Schlegelstraße 2, 53113 Bonn
Stefanie Zillikens, Head of PR; Tel. +49 – 228 82300107, s.zillikens@htgf.de, www.htgf.de
BIOCOM AG & medtech zwo, Lützowstr. 33-36, 10785 Berlin
Sandra Wirsching, Leiterin Dienstleistungen/Redaktionsleiterin; Tel.: +49 (0)30-264 921-63, s.wirsching@biocom.de, www.biocom.de
Stay up to date
Subscribe now and receive the latest press releases on investments and other news from High-Tech Gründerfonds. We inform you about important developments at HTGF and provide you with interesting news from our portfolio. Whether it’s a successful exit, a new exciting investment or HR news – you’ll be the first to know!
Cultimate Foods raises 2.3 million EUR seed funding from leading Biotech and Foodtech investors to revolutionize the alternative meat industry
Successful Exit for HTGF: DocuWare Announces Acquisition of natif.ai
